跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xorimax 250mg coated tablets - HSA Drug Approval Details
Approvals
/
HSA
/
Xorimax 250mg coated tablets
Approved
THERAPEUTIC
Xorimax 250mg coated tablets
Sandoz Private Limited (Intermediate)Pencef Pharma GmbHSandoz GmbHAurobindo Pharma Limited (Intermediate)
🇸🇬 Health Sciences Authority
Approval Date
Jun 1, 2007
Approval ID
e6ba4e2d98ba0b29
Company
Sandoz Private Limited (Intermediate)Pencef Pharma GmbHSandoz GmbHAurobindo Pharma Limited (Intermediate)
Type
Therapeutic
Approval Details
Approval Id
e6ba4e2d98ba0b29
Drug Name
Xorimax 250mg coated tablets
Product Name
Xorimax 250mg coated tablets
Approval Number
SIN13287P
Approval Date
2007-06-01
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Licence Holder
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, COATED
Route Of Administration
ORAL
Atc Code
J01DC02
Atc Item Name
cefuroxime
Pharma Manufacturer Name
SANDOZ SINGAPORE PTE. LTD.
Company Detail Path
/organization/sandoz-singapore-pte-ltd
Active Ingredients
CEFUROXIME AXETIL 300.72 mg EQV CEFUROXIME
250 mg
CEFUROXIME AXETIL 300.72 mg EQV CEFUROXIME
250 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 1, 2007
Approval ID
e6ba4e2d98ba0b29
Type
Therapeutic
Back to HSA Approvals